India's Intas acquires USA's BPD Inc

29 June 2008

Indian company Intas Biopharmaceuticals has acquired US-based biotechnology enterprise Biologics Process Development Inc (BPD Inc) based in Poway, California. With the acquisition process underway, both Intas and BPD Inc are actively pursuing plans to work closely toward fulfilment of common business objectives in the area of biologics contract research and manufacturing services (CRAMS). No financial details of the transaction have been revealed.

Intas says that this development will facilitate and assist its foray into the US marketplace especially to expand its CRAMS business. With mutual understanding and agreement between the two companies, Scott Brown, founder, president and chief scientific officer of the US concern will continue in both executive capacities.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight